Vestibular Schwannoma Surgical management and outcomes

Slides:



Advertisements
Similar presentations
Management of Acoustic Neuroma NEMROCK Experience Mohamed Abdulla (M.D.) Ass. Professor of Clinical Oncology Kasr El-Aini School of Medicine.
Advertisements

Comparison of Direct and Indirect Bypass for Moyamoya Disease
Cranial Nerve Lesion Acoustic Neuroma Presented By: Emma Morales Gigi Sanchez Christine Achenbach Josefina Delgado.
Cerebellopontine Angle Tumors John K. Yoo, M.D. Jeffrey T. Vrabec, M.D. May 7, 1997.
Acoustic Neuroma & Glomus Tympanicum
Radiofrequency Ablation of Lung Cancer
Hemangioblastoma.
Surgical Results from Chiari Decompression: Comparing Duroplasty versus Dural Splitting Techinques John A. Jane, Jr., M.D. Associate Professor of Neurosurgery.
Thomas F. DeLaney MD, Aashish D. Bhatt MD, Alex Jacobson BS, Richard Y. Lee MD, PhD, Christine Giraud BS, Joseph H. Schwab MD, MS, Francis J. Hornicek.
Management of Meningiomas. DIAGNOSTIC TOOLS MRI –Dural tail, edema CT SCAN:CT SCAN –Hyperostosis, intratumoral calcifications ANGIOGRAPHY: –embolization.
Cancer of middle ear Chunfu Dai M.D & Ph.D. Background Primary tumor in middle cavity Primary tumor in middle cavity Predilection in y Predilection.
Outcome Following Limb Salvage Surgery and External Beam Radiotherapy for High Grade Soft Tissue Sarcomas of the Groin and Axilla Rapin Phimolsarnti M.D.
Tinnitus in 44 y/o female Richard Lukose. Presents to family doctor A 44 y/o female Tinnitus in right ear for 1 month, worsening PMHx: obesity Medications:
Tumors of the CNS can be: Primary Secondary
International Survey on Management of Paediatric Ependymomas: Preliminary Results Guirish Solanki ¥, G Narenthiran § Department of Neurosurgery ¥ Birmingham.
PG Intraventricular Meningioma Alexander Taghva, MD Parham Yashar, MD Steven Giannotta, MD.
Acoustic Neuroma (Vestibular Schwannoma) Diagnosis and treatment
Proton Therapy for Chondrosarcomas of the Skull Base and Cervical Spine: Long-term Experience at Loma Linda University Medical Center D. Y. Kim 2, R. W.
Stereotactic Gamma Knife Raiodusrgery For Vestibular Schwannoma Ming-Hsi Sun Hung-Chuan PanChiung-Chyi Shen Neurosurgery Taichung Veterans General Hospital.
Case Presentation Conference -Memorial- January 24, 2002 Jason Hunt M.D. Brian Kerr M.D. Peter Rigby M.D.
Long-term follow-up of a prospective trial of pre-operative external-beam radiation and post-operative brachytherapy for retroperitoneal sarcoma LA Mikula,
Learn More At: Dose-Response and Dose- Complications Relationships in Stereotactic Radiosurgery for Trigeminal Neuralgia Sandra.
Anterior temporal lobectomy for epilepsy: success and shortcomings Dario J. Englot, visiting student Yale MD/PhD Program September 24, 2009 Department.
Patellar Instability Clint R Beicker MD June 5, 2015 Please note change from program.
Predictive factors for early facial nerve function after vestibular schwannoma surgery Gerganov VM, Nouri M, Samii A, Samii M International Neuroscience.
What is the Preferable Treatment Option for T1/T2 Low Rectal Cancer? Christopher H. Crane, M.D. Program Director, GI Section Department of Radiation Oncology.
Quantitative Dosimetric Analysis Of Patterns Of Local Relapse After IMRT For Primary Extremity Soft Tissue Sarcomas Ryan M. Lanning, Sean L. Berry, Michael.
Brain Abscess & Intracranial Tumors
Quantifying the Morbidity of the Unplanned Sarcoma Excision
What’s up with Acoustic Neuromas? Nancy Fuller, M.D. PCC September 27, 2006.
AVM for “Dummies” Cezar Jose Mizrahi MD Neurosurgery Department Hadassah Ein-Kerem
Thyroid Debate (Papillary Thyroid Cancer: Extent of Thyroidectomy) 30 Aug 2007 Surgery-OMMC JGGuerra, MD HCruz, MD.
Chiba Cancer Center, Chiba, Japan Shintaro Iwata Tsukasa Yonemoto Yoko Hagiwara Takeshi Ishii Division of Orthopedic Surgery Akinobu Araki Dai Ikebe Division.
Multiple Craniotomies in the Management of Multifocal and Multicentric Glioblastoma Raymond Sawaya, M.D.
12/6/20151 Cochlear implants in the older patient Mark Pyle MD Professor of surgery and Academic Vice Chair Division of Otolaryngology.
NF2 and Hearing Preservation After Gamma Knife Treatment Reem Emad, MD Radiation Oncologist National Cancer Institute, Cairo University And Gamma Knife.
Aggressive meningioma Robert M. Koffie Neurosurgery sub-intern July 19, 2012 Department of Neurosurgery Massachusetts General Hospital Harvard Medical.
Petroclival meningiomas. Anatomic landmarks The clivus – localization: Part of the skull base, behind the dorsum sellae. The posterior end of the midline.
Role of Sentinel Lymph Node Biopsy in the Staging of Synovial, Epithelioid, and Clear Cell Sarcomas. Ugwuji N. Maduekwe, Francis J. Hornicek, Dempsey S.
Dr Mark Saunders Christie Hospital and Paterson Institute of Cancer Research “ Rectal cancer radiotherapy – why do we give it and how do we do it?”
Identification of localized rectal cancer (RC) patients (pts) who may NOT require preoperative (preop) chemoradiation (CRT). D. Roda 1, M. Frasson 2, E.
Purpose/Objectives: A percentage of patients receiving stereotactic radiosurgery (SRS)/fractionated stereotactic radiotherapy (FSRT) for Schwannomas initially.
Central Auditory Nervous System Disorders Lecture 16.
Nick Wegner 4/22/10 The Use of CT in Diagnosing Pulmonary Metastases in Osteosarcoma.
Pancreatic Tumors in Children Presented by Damien W. Carter, MD.
It is essential to obtain the exact history of the hypersalivation as well as a thorough and complete past medical history. Oral evaluation should be performed,
Surgery for Metastatic Brain Tumor from Breast Cancer
Radical Prostatectomy versus Watchful Waiting in Early Prostate Cancer Anna Bill-Axelson, M.D., Lars Holmberg, M.D., Ph.D., Mirja Ruutu, M.D., Ph.D., Michael.
1 st Pyongyang International Neurosurgery Symposium, DPRK October, 2015 Marco Lee MD PhD FRCS Associate Professor Dept. of Neurosurgery Stanford.
Evaluating the Clinical Outcomes of Sixty-Three Patients Treated with Gamma Knife as Salvage Therapy for Glioblastoma Multiforme Erik W Larson, Halloran.
Neurosurgery Department Shuang Ho Hospital New Taipei City, Taiwan Wei-Lun Lo, M.D. THE APPLICATION OF PERFEXION GAMMA KNIFE RADIOSURGERY FOR INFRA-SKULL.
Department of Clinical Radiotherapy, Royal Marsden Hospital, Sutton, Surrey SM2 5PT, UK R4 한재준 1.
Brain imaging prior to lung cancer resection
Toxicity of Gamma Knife Radiosurgery in the Treatment of Intracranial Tumors in Patients With Collagen Vascular Diseases or Multiple Sclerosis  Dot Lowell,
Gamma Knife Radiosurgery for Large Vestibular Schwannomas: A Canadian Experience Zeiler FA1, Bigder M1, Kaufmann AM1, McDonald PJ1, Fewer D1, Butler J2,
Extending intracranial treatment options with Leksell Gamma Knife® Icon™ Key Statements from Customer Perspective by University Medical Centre Mannheim.
Brain imaging prior to lung cancer resection
Treatment With Continuous, Hyperfractionated, Accelerated Radiotherapy (CHART) For Non-Small Cell Lung Cancer (NSCLC): The Weston Park Hospital Experience.
Leksell Gamma Knife® Icon™
Treatment strategy of intracranial hemangiopericytoma
Daniel E. Roos, B. Sc. (Hons), M. D. , FRANZCR. , Brian P
Gamma Knife Radiosurgery
Diagnostic Neuroradiology Case
Adjuvant Radiation is Required for Gastric Cancer
Jugular bulb abnormalities
Recurrent Sudden Sensorineural Hearing loss: Review of 30 Cases with the Clinical manifestations and Outcomes Pei-Hsuan Wu, Cheng-Ping Shih Department.
Acoustic neuroma Chunfu Dai M.D & Ph.D.
Outcome with respect to seizures as a percentage of patients in different Engel’s classes at different time intervals. Outcome with respect to seizures.
Nicholas D. Fletcher, MD¹ Charles E. Johnston III, MD²
Presentation transcript:

Vestibular Schwannoma Surgical management and outcomes Ching-Jen (Jared) Chen Visiting Sub-Intern University of Virginia

Patient MM 48yo M w/ L-sided tinnitus and dysequilibrium since 2009. MRI 2010 revealed 5mm L vestibular schwannoma (purely intracanalicular). No intervention, followed with serial scans. MRI 2012 revealed schwannoma had extended to just outside the IAC. Audiogram showed mild L sensorineural hearing loss. Referred to MGH for surgical consideration.

Patient MM (cont’d) PMH: SH: Denies tobacco and illicits, rare EtOH. Hx of Afib w/ spontaneous conversion to NSR Viral pericarditis S/p R knee surgery S/p R shoulder surgery SH: Denies tobacco and illicits, rare EtOH. FH: Non-contributory, no hx of vestibular schwannomas. MEDS: ASA 81 QDaily ALL: NKDA EXAM: NI, except slightly decreased hearing in L ear Decided to undergo microsurgical resection via retrosigmoid approach

T1-PostGad 2010 2012 2013 5mm L Vestibular Schwannoma, purely intracanalicular. Enlarging L Vestibular Schwannoma, 11mm. Projects just beyond medial aspect of porous acusticus. 6 mo s/p microsurgical GTR, via retrosigmoid approach. W/o evidence of residual/recurrent tumor.

Vestibular Schwannoma Usually arise from the superior division of vestibular n. Histology: Antoni A, Antoni B, and Verocay Bodies. Comprising 8-10% of intracranial tumors. Annual incidence ~1.5 cases/100,000. Typically become symptomatic after age 30. Most common symptoms: hearing loss, tinnitus, and dysequilibrium. >95% are unilateral. B A Wippold FJ et al.

Treatment options Microsurgery Radiosurgery Middle Fossa approach Translabyrinthine approach Retrosigmoid approach Radiosurgery Mayfield clinic

Middle Fossa Approach Gonzalez LF et al. Usually selected for smaller (<25mm) and laterally place tumors. Potential damage to temporal lobe w/ risk of seizures.

Retrospective review; 46 patients, middle fossa approach. Mean follow-up time: 1.8 yr. Mean tumor size 8.3mm. Facial n. Excellent/good (House-Brackmann Grade I-II) functional preservation: 89.1%. Not correlated w/ tumor size. Cochlear n. Functional hearing (AAO-HNS Class A-B) preservation: 63.2% Hearing preservation related to tumor size.

Translabyrinthine Approach Allows resection of tumors of different sizes. Disadvantage: Sacrifices hearing Longer procedure Gonzalez LF et al.

Retrospective review, 1244 patients, translabyrinthine approach. All patients at least 12mo of f/u. Gross total resection 84%, near-total 13.7%, subtotal 2.2%. Facial n. Excellent/good (House-Brackmann Grade I-II) functional preservation: 70.3% Tumor size significantly correlates w/ post-op facial n. function.

Retrosigmoid Approach Most commonly used approach. Allows resection of tumors of different sizes and wide view of cisternal component of tumor. Disadvantage: Cerebellar retraction (not a problem for smaller tumors, <40mm) Less access to facial/cochlear n. in distal IAC Headaches Gonzalez LF et al.

Retrospective review; 200 consecutive patients, retrosigmoid approach. Mean follow-up time: 24 mo. Gross total resection: 98%, Subtotal resection: 2%. Tumor recurrence: 0.5%. Facial n. Excellent/good (House-Brackmann Grade I-II) functional preservation: 62%. Tumor size significantly correlates w/ post-op facial n. function (p<0.05). Cochlear n. Functional hearing (New Hannover Classification Grade I-III) preservation: 51%. Hearing preservation related to tumor size and extension, and pre-op hearing level (p<0.05).

Radiosurgery Alone or in conjunction with surgery. Usually reserved for small to medium sized tumors, or patients who are poor surgical candidates.

Retrospective review, 190 patients treated with GKRS. Primary treatment 70.5% and adjunctive 29.5%. Median margin dose 13Gy, tumor volume 3.6cm3, f/u 109mo. Overall tumor control rate 89.5%. Estimated 3-, 5-, 10- and 15-year tumor control rates: 95%, 93%, 86%, and 70%, respectively. Hearing preservation rate 75%. Estimated 3-, 5-, and 10-year tumor control rates:, 96%, 92%, and 70% respectively. Facial n. function (House-Brackmann Grade I-II) preservation 98.6%. Tumor control was significantly affected by tumor volume.

Patient MM (cont’d) At 6mo f/u, pt has been doing well. Stable tinnitus and hearing loss. Exam unchanged, incision c/d/i. No specific complaints. F/u visit in 6mo w/ MRI and audiogram.

Conclusions Microsurgery appears to offer better tumor control rates, whereas radiosurgery seems to have higher hearing preservation. Treatment selection should be tailored to each individual patient and tumor characteristics. Surgeon/institution experience should also be taken into consideration. Gonzalez LF et al.

Acknowledgements Mark E. Shaffrey, MD John A. Jane Sr., MD PhD Justin S. Smith, MD PhD Christopher I. Shaffrey, MD Jason P. Sheehan, MD PhD Robert L. Martuza, MD William T. Curry, MD Department of Neurosurgery

References Samii M, Gerganov V, Samii A: Improved preservation of hearing and facial nerve function in vestibular schwannoma surgery via the retrosigmoid approach in a series of 200 patients. J Neurosurg 105: 527-535. 2006. Gonzalez LF, Lekovic GP, Porter RW, Syms MJ, Daspit CP, Spetzler RF: Surgical approaches for resection of acoustic neuromas. Barrow Quarterly 20(4): 22-32. 2004. Wippold FJ, Lubner M, Perrin RJ, Lammle M, Perry A: Neuropathology for the neuroradiologist: antoni a and antoni b tissue patterns. AJNR 28: 1633-1638. 2007. Sun S, Liu A: Long-term follow-up studies of gamma knife surgery with a low margin dose for vestibular schwannoma. J Neurosurg 117: 57-62. 2006. Springborg JB, Fugleholm K, Poulsgaard L, Caye-Thomasen P, Thomsen J: Outcome after translabyrinthine surgery for vestibular schwannomas: report on 1244 patients. J Neurol Surg B 73: 168-174. 2012. Kutz JW, Scoresby T, Isaacson B, Mickey BE, Madden CJ, Barnett SL, Coimbra C, Hynan LS, Roland PS: Hearing preservation using the middle fossa approach for the treatment of vestibular schwannoma. Neurosurgery 70: 334-341. 2012.